PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'KU Leuven - Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.\', \'CALIBR - Department of Medicinal Chemistry, The Scripps Research Institute, La Jolla, CA, USA.\', \'CALIBR - Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.\', \'Gilead Sciences, Inc., Foster City, CA, USA.\', \'KU Leuven - Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium. Electronic address: johan.neyts@kuleuven.be.\', \'KU Leuven - Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium. Electronic address: dirk.jochmans@kuleuven.be.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0166-3542(21)00112-110.1016/j.antiviral.2021.105122
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 34186107
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all